logo
Symptoms of climate change such as extreme heat can impact insect activity

Symptoms of climate change such as extreme heat can impact insect activity

Yahoo4 hours ago

Climate change symptoms like rising temperatures in Augusta are affecting gnat and other insect activity.
'Changing Climate can affect them in some ways,' said Elmer Gray, entomologist, at the University of Georgia. 'One thing that's going to help them is staying warm at night. Wednesday night I don't know if it got below 77 degrees. We know that insects like warmer temperatures. Warmer temperatures mean a longer growing season.'
Gray added, 'They may grow longer into the fall, if it stays warmer into October. So they'll have more chances to create more generations in a life cycle.'
Gray said insects need humidity.
'We've had so much rain throughout the end of spring and into the beginning of summer,' said Gray. 'The temperatures have warmed up, so everything is starting to grow faster. They completed their life cycle quicker. When we have lots of moisture in the environment, whether it's in the soil, standing water collecting in containers, all of these things provide habitats that increase the productivity of a wide range of insects.'
'The term gnat is kind of interesting,' said Gray. 'Gnat is a general term for a small fly. So, what you're calling a gnat in Augusta is going to be a different insect than what they call a gnat in Pennsylvania. Gnat is a general term, typically for insects that swarm about our faces. Black flies and other gnats are attracted to the carbon dioxide in our breath.'
Gray added, 'It tells them there's an animal there. Then they're going to get closer and try to pick up the final cues as to whether you're the kind of animal that they like to feed on.'
'As far as the eye gnats they're attracted to the moist membranes,' he said. 'So your eyes are where they're drawn to. For other animals, they'll get around the genitals and other places. When we say Diptera or fly that means insects that have two wings. A lot of our common insects that we deal with are a type of fly.'
Different types of flies according to Gray:
House flies
Black flies
Blow flies
Mosquitoes
'So right now is peak season,' said Gray. 'Now, if it stops raining and everything starts drying up, if we go into drought conditions, the insects suffer. It's very common for the insect populations to kind of go down in the heat of the summer. If you think it's hot outside for us, well, it's hot outside for them too. Insects are very susceptible to drying out.'
'It tends to be drier from August to September,' said Gray. 'If we have a hurricane that could mean a lot of flooding. Then things start getting wet again.'
'For mosquitoes, you want to be very diligent about eliminating standing water around your homes and in your neighborhood and communities,' he said. ' Richmond County has a good mosquito control program down there in Augusta. If people are having problems with mosquitoes, they should reach out to the Richmond County Public Health to let them know what's going on.'
Tips for homeowners according to the Centers for Disease Control and Prevention:
Empty or throw out any items that hold water like tires, buckets, planters, toys, pools, birdbaths, flower pot saucers, or trash containers.
Ensure screens are secure, free of tears, and properly installed to keep insects out while allowing fresh air in.
When sleeping outdoors or in areas with poor screening, use a mosquito bed net.
Wear loose-fitting, long-sleeved shirts and pants.
'I'm a homeowner,' said Gray. 'It's easy to have a bucket for picking up sticks in the yard, or the old boat that you use once in a while. So you really need to be diligent about eliminating standing water. Most of the biting flies are attracted to darker colors. So light colored, loose fitting clothing will help. If you're planning on going to a ball game or going to watch fireworks on the Fourth of July you might want to apply an EPA approved repellent to your exposed skin.'
Gray said there's a lot of misinformation surrounding natural ways to get rid of pests.
"The plants that have oils that can repel insects have to be crushed and processed," said Gray. "So the Citronella plant is not good. There have been studies conducted that show mosquitoes will actually land on it. Yes, citronella oil can repel mosquitoes to some degree. Oil of lemon eucalyptus is one thing that works. T's naturally derived and very effective."
This reporting content is supported by a partnership with several funders and Journalism Funding Partners.
Erica Van Buren is the climate change reporter for The Augusta Chronicle, part of the USA TODAY Network. Connect with her at EVanBuren@gannett.com or on X: @EricaVanBuren32.
This article originally appeared on Augusta Chronicle: Impacts of extreme heat may mean more insect, pests activity

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Northrop Grumman tests future Artemis booster, but suffers destructive ‘anomaly'
Northrop Grumman tests future Artemis booster, but suffers destructive ‘anomaly'

Yahoo

timean hour ago

  • Yahoo

Northrop Grumman tests future Artemis booster, but suffers destructive ‘anomaly'

Northrop Grumman saw some fiery drama during a test of a more powerful version of the solid rocket booster that would be used if NASA's Artemis program ever gets to its ninth launch using the beleaguered Space Launch System rocket. During a Thursday live stream by NASA of a static fire of the 156-foot-long Booster Obsolescence and Life Extension (BOLE) solid rocket motor, the end nozzle blew apart, sending debris flying across the camera followed by a black plume of smoke rising up from Northrop's Promontory, Utah test site. 'Whoa,' said one of the test controllers during the stream, just after the 100-second mark of the hot fire. Laying on its side, the booster was burning through the same amount of fuel that it would as if used on a launch. Northrop Grumman officials addressed the nozzle's demise in a press release later Thursday. 'Today's test pushed the boundaries of large solid rocket motor design to meet rigorous performance requirements,' said Jim Kalberer, Northrop Grumman's vice president of propulsion systems. 'While the motor appeared to perform well through the most harsh environments of the test, we observed an anomaly near the end of the two-plus minute burn.' The test is for a booster that wouldn't fly until at least next decade, and only if NASA sticks with SLS as a rocket option for its Artemis missions. 'As a new design, and the largest segmented solid rocket booster ever built, this test provides us with valuable data to iterate our design for future developments,' Kalberer said. Under the current NASA plan, the first eight Artemis launches use an SLS rocket with boosters that produce 3.4 million pounds of thrust each. The pair, combined with the core stage, created 8.8 million pounds of thrust on the Artemis I launch in 2022, which still is the most powerful rocket to ever make it into orbit. The BOLE version would increase thrust to 4 million pounds each, which would push SLS to near 10 million pounds of thrust on Artemis IX. The Trump administration's proposed budget for NASA, though, wants to kill off the use of the SLS rocket after Artemis III, although Congress is the ultimate decision-maker on what gets funded. So until directed otherwise, contractors continue to work on future versions of the SLS. Northrop Grumman's solid rocket boosters for Artemis are enhanced versions of similar boosters used during the Space Shuttle Program. The BOLE design is a solution to components no longer in production. The update uses a carbon fiber composite case and a different propellant formula among other features. The goal is a 10% increase in booster performance over the boosters used on Artemis I. That would equate to SLS being able to carry another 11,000 pounds of payload to lunar orbit. The nozzle issue was reminiscent of another Northrop Grumman booster problem seen in 2024. SpaceX Crew Dragon with 4 Axiom Space astronauts docks with space station Kennedy Space Center goes retro for Y2K after-hours event SpaceX launches historic mission to space station on new Crew Dragon dubbed 'Grace' Space Coast launch schedule With SLS rocket future uncertain, L3Harris still cranking out engines That's when a nozzle flew off of one of the boosters used on the United Launch Alliance Vulcan Certification-2 mission from Cape Canaveral. That incident contributed to a delay in the Space Force giving ULA the OK to fly national security missions. Northrop Grumman officials, though, said the ULA and Artemis boosters are not directly related. 'It is an entirely separate product,' said Mark Pond, senior director of NASA programs for Northrop Grumman's propulsion systems during an Artemis II media day last December at Kennedy Space Center. Artemis II is slated to launch no later than April 2026 on what would be the first crewed mission sending four astronauts on a trip around the moon, but not landing on it. 'From a concern standpoint, we've met all of our requirements, we've done all of our testing, we've met all of our acceptance tests and our delivery requirements, and for that reason, we are not concerned from an Artemis II perspective,' he said.

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment
Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment

Yahoo

timean hour ago

  • Yahoo

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment

Lantheus Holdings Inc. (NASDAQ:LNTH) is one of the most undervalued US stocks according to analysts. On June 20, Lantheus Holdings announced its participation in the newly launched FIBRE Consortium, which is a collaborative initiative with Pfizer Inc. (NYSE:PFE) and Lumina Pharmaceuticals. The consortium's primary goal is to revolutionize the treatment of fibrotic diseases by using advanced imaging biomarkers. The FIBRE (Fibrosis Imaging Biomarker Research & Evaluation) Consortium aims to accelerate biomarker validation and reduce the costs of clinical trials for fibrotic diseases through innovative imaging technologies. Lantheus's contribution includes supplying LNTH-1363S, which is a PET tracer targeting Fibroblast Activation Protein/FAP. FAP is a protein expressed exclusively by activated fibroblasts. A medical professional performing a pulmonary function assessment on a patient. This biomarker, along with Lumina's [⁶⁸Ga]CBP8 PET/MRI tracer for Collagen Type I, will enable the quantification of fibrosis burden and treatment response within weeks, and potentially reduce trial durations by 60% and costs by ~$400 million. Initial studies will focus on Metabolic Dysfunction-Associated Steatohepatitis/MASH, with potential expansion into other fibrotic conditions. Lantheus Holdings Inc. (NASDAQ:LNTH) develops, manufactures, and commercializes diagnostic and therapeutic products that assist in the diagnosis and treatment of heart, cancer, and other diseases. While we acknowledge the potential of LNTH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment
Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment

Yahoo

timean hour ago

  • Yahoo

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment

Lantheus Holdings Inc. (NASDAQ:LNTH) is one of the most undervalued US stocks according to analysts. On June 20, Lantheus Holdings announced its participation in the newly launched FIBRE Consortium, which is a collaborative initiative with Pfizer Inc. (NYSE:PFE) and Lumina Pharmaceuticals. The consortium's primary goal is to revolutionize the treatment of fibrotic diseases by using advanced imaging biomarkers. The FIBRE (Fibrosis Imaging Biomarker Research & Evaluation) Consortium aims to accelerate biomarker validation and reduce the costs of clinical trials for fibrotic diseases through innovative imaging technologies. Lantheus's contribution includes supplying LNTH-1363S, which is a PET tracer targeting Fibroblast Activation Protein/FAP. FAP is a protein expressed exclusively by activated fibroblasts. A medical professional performing a pulmonary function assessment on a patient. This biomarker, along with Lumina's [⁶⁸Ga]CBP8 PET/MRI tracer for Collagen Type I, will enable the quantification of fibrosis burden and treatment response within weeks, and potentially reduce trial durations by 60% and costs by ~$400 million. Initial studies will focus on Metabolic Dysfunction-Associated Steatohepatitis/MASH, with potential expansion into other fibrotic conditions. Lantheus Holdings Inc. (NASDAQ:LNTH) develops, manufactures, and commercializes diagnostic and therapeutic products that assist in the diagnosis and treatment of heart, cancer, and other diseases. While we acknowledge the potential of LNTH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store